Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor–tezacaftor–ivacaftor, Germany, 2012–2021
European Respiratory Journal · 2023-01 · 61 (1) · 2201402
DOI: 10.1183/13993003.01402-2022 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 14.12.2022. Verfasst von Felix C Ringshausen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany Ringshausen.Felix@mh-hannover.de. Hauptthemen laut MEDLINE: Cystic Fibrosis, Lung Transplantation. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany Ringshausen.Felix@mh-hannover.de.
- Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.
- European Reference Network on Rare and Complex Respiratory Diseases (ERN-LUNG), Frankfurt, Germany.
- Department of Respiratory Medicine, Hannover Medical School (MHH), Hannover, Germany.
- Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School (MHH), Hannover, Germany.
- Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School (MHH), Hannover, Germany.
ORCID-Profile: Felix C Ringshausen, Anna-Maria Dittrich, Tobias Welte
Zitieren
APA
Ringshausen, F. C., Sauer-Heilborn, A., Büttner, T., Dittrich, A. M., Schwerk, N., Ius, F., Nährlich, L., Welte, T., & Greer, M. (2023). Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor–tezacaftor–ivacaftor, Germany, 2012–2021. European Respiratory Journal, 61(1), 2201402. https://doi.org/10.1183/13993003.01402-2022
Vancouver
Ringshausen FC, Sauer-Heilborn A, Büttner T, Dittrich AM, Schwerk N, Ius F, et al. Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor–tezacaftor–ivacaftor, Germany, 2012–2021. European Respiratory Journal. 2023;61(1):2201402. doi:10.1183/13993003.01402-2022
BibTeX
@article{Ringshausen2023,
author = {Ringshausen, Felix C and Sauer-Heilborn, Annette and Büttner, Tina and Dittrich, Anna-Maria and Schwerk, Nicolaus and Ius, Fabio and Nährlich, Lutz and Welte, Tobias and Greer, Mark},
title = {Lung transplantation for end-stage cystic fibrosis before and after the availability of elexacaftor–tezacaftor–ivacaftor, Germany, 2012–2021},
journal = {European Respiratory Journal},
year = {2023},
volume = {61},
number = {1},
pages = {2201402},
doi = {10.1183/13993003.01402-2022}
}
EUVIMED